top of page
O nás: Who We Are

Vieš, že...
Približne 1 z 40 ľudí je nositeľom genetickej mutácie, ktorá spôsobuje SMA (spinálnu muskulárnu atrofiu), čo z nej robí jedno z najbežnejších genetických ochorení.

In the MENA region, the lack of standardized referral pathways for Duchenne Muscular Dystrophy (DMD) causes delays in diagnosis and treatment. We aim to build AI-driven software to analyze low MRI muscle tissue scan to provide early detection and comprehensive evaluation of disease management.

OUR MAIN PROJECTS INCLUDE:

medical problem solving contest and summer academy focused on clinical practice

journalism for young scientists with a focus on research

weekend workshops 

*European Commission, report on Slovakia 2020

Screenshot 2024-07-09 134341.png

Our
Mission and
Impact

AI-Powered Muscle Analysis

Easy to use for clinicians

Easy access for patients

Early and reliable diagnosis

IMG_1119_edited.jpg

Terezia Jurasova

Founder of MyoMetricsMRI

1.png

Call 

+421 902 950 910

Email 

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Connect

Slovakia

  • Facebook
  • Instagram

mMEDCON

We make medical careers and research accessible and attractive to ambitious students through experiential education, competitions, and workshops.

©2025 mMEDCON. All rights reserved.

bottom of page